11/13/2024
11:31 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024
6:10 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2024
8:10 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2024
10:46 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024
8:38 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024
5:00 AM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Monopar Therapeutics (Subject)
| Form SC 13G | |
10/21/2024
8:48 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
10/11/2024
5:01 AM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
| Form SC 13G | |
10/07/2024
5:38 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/01/2024
9:45 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024
5:42 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024
5:44 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024
5:27 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024
12:34 PM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
5:21 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024
9:50 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
5:05 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2024
5:21 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024
9:11 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024
5:26 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024
5:00 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/26/2024
5:42 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2024
8:06 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
5:15 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024
9:07 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024
5:07 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2024
4:00 PM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/25/2024
5:12 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
5:07 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2024
5:38 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024
5:21 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2024
9:14 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024
9:02 AM | AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
06/03/2024
9:23 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024
9:29 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024
5:35 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
5:15 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
5:08 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2024
5:32 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024
5:41 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024
9:09 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
05/07/2024
6:31 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024
5:49 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
6:18 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
5:52 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
5:26 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024
12:22 PM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024
5:55 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
5:14 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
5:14 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024
5:22 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024
7:45 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024
6:54 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2024
6:28 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024
4:27 PM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Fusion Pharmaceuticals Inc. (Subject)
| Form DFAN14A | |
03/19/2024
3:31 PM | AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form F-3ASR | |
03/19/2024
5:02 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
6:12 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2024
6:29 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
5:30 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
5:34 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
9:06 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
9:11 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
6:21 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form CERT | |
03/05/2024
3:40 PM | AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 8-A12B | |
03/04/2024
5:33 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/01/2024
9:39 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2024
5:19 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
8:14 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
8:19 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
5:08 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024
7:32 AM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
02/21/2024
7:13 AM | AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
02/21/2024
5:04 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
8:25 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
6:51 AM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
02/20/2024
6:49 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
6:12 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:52 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:47 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:27 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2024
9:13 AM | ADC Therapeutics SA (Subject)
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
| Form SC 13G/A | |
02/08/2024
5:40 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/01/2024
9:30 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/24/2024
4:23 PM | AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/19/2024
7:46 AM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
01/19/2024
7:31 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/10/2024
7:39 PM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
01/02/2024
9:53 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
7:03 AM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T | |
12/27/2023
6:09 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
12/26/2023
4:25 PM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/22/2023
5:19 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023
9:20 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
4:15 PM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
4:15 PM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-C | |
12/12/2023
5:26 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
10:50 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
10:53 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
5:26 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
